FDA NDC Directory · JSON-LD · Markdown

BIVALIRUDIN

NDC 55150-210 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Labeler / ManufacturerEugia US LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA205962
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsBIVALIRUDIN (250 mg/1)
Marketing started20180727
Package count1

External sources

Source: openFDA. Public-domain (CC0).